Weak US momentum and regulatory headwinds drag Sun Pharma below Sensex and Nifty despite steady domestic gains ...

Sun Pharmaceutical Industries Ltd. informed exchanges that the US Food and Drug Administration (FDA) has classified its Halol facility as “Official Action Indicated (OAI)” following an inspection ...

(Reuters) – Indian drugmaker Sun Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration had determined that its Halol plant in the western state of Gujarat was not compliant ...

A guard walks inside the office of Sun Pharmaceutical Industries Ltd in Mumbai (Reuters) -Indian drugmaker Sun Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration ...

Sun Pharma's big manufacturing site in Gujarat is still on the US FDA's import alert list as of September 2025. After a June inspection, the FDA found ongoing issues related to non-compliance with ...

Sun Pharma’s share price continues to be under pressure and is down 2% in trade today. Nomura maintained its ‘Neutral’ rating on the stock and retained a target price of Rs 1,970 per share. This ...

One of India’s largest drugmaker shares slipped on Monday, June 16, after the US Food and Drug Administration (US FDA) issued eight observations on the pharma player’s Halol manufacturing facility in ...